201 related articles for article (PubMed ID: 32529753)
1. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study.
Gutierrez-Mariscal FM; Cardelo MP; de la Cruz S; Alcala-Diaz JF; Roncero-Ramos I; Guler I; Vals-Delgado C; López-Moreno A; Luque RM; Delgado-Lista J; Perez-Martinez P; Yubero-Serrano EM; Lopez-Miranda J
Mol Nutr Food Res; 2021 Jan; 65(1):e1901290. PubMed ID: 32529753
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
de la Cruz-Ares S; Cardelo MP; Gutiérrez-Mariscal FM; Torres-Peña JD; García-Rios A; Katsiki N; Malagón MM; López-Miranda J; Pérez-Martínez P; Yubero-Serrano EM
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963378
[TBL] [Abstract][Full Text] [Related]
3. Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial.
Gutierrez-Mariscal FM; Podadera-Herreros A; Alcalá-Diaz JF; Cardelo MP; Arenas-de Larriva AP; Cruz-Ares S; Torres-Peña JD; Luque RM; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
Diabetes Metab; 2024 Jan; 50(1):101503. PubMed ID: 38097011
[TBL] [Abstract][Full Text] [Related]
4. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
Roncero-Ramos I; Gutierrez-Mariscal FM; Gomez-Delgado F; Villasanta-Gonzalez A; Torres-Peña JD; Cruz-Ares S; Rangel-Zuñiga OA; Luque RM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Camargo A; Alcalá-Diaz JF; Lopez-Miranda J
Transl Res; 2021 Dec; 238():12-24. PubMed ID: 34298148
[TBL] [Abstract][Full Text] [Related]
5. Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.
Lopez-Moreno J; Quintana-Navarro GM; Camargo A; Jimenez-Lucena R; Delgado-Lista J; Marin C; Tinahones FJ; Striker GE; Roche HM; Perez-Martinez P; Lopez-Miranda J; Yubero-Serrano EM
Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28233454
[TBL] [Abstract][Full Text] [Related]
6. Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study.
Yubero-Serrano EM; Gutiérrez-Mariscal FM; Gómez-Luna P; Alcalá-Diaz JF; Pérez-Martinez P; López-Miranda J
Clin Investig Arterioscler; 2023; 35(3):105-114. PubMed ID: 36184301
[TBL] [Abstract][Full Text] [Related]
7. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial.
Podadera-Herreros A; Alcala-Diaz JF; Gutierrez-Mariscal FM; Jimenez-Torres J; Cruz-Ares S; Arenas-de Larriva AP; Cardelo MP; Torres-Peña JD; Luque RM; Ordovas JM; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
Clin Nutr; 2022 Feb; 41(2):552-559. PubMed ID: 35030530
[TBL] [Abstract][Full Text] [Related]
8. Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.
Podadera-Herreros A; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Alcala-Diaz JF; Ojeda-Rodriguez A; Rodriguez-Cantalejo F; Cardelo MP; Rodriguez-Cano D; Torres-Peña JD; Luque RM; Ordovas JM; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
Nutr Diabetes; 2024 May; 14(1):27. PubMed ID: 38755195
[TBL] [Abstract][Full Text] [Related]
9. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
Roncero-Ramos I; Alcala-Diaz JF; Rangel-Zuñiga OA; Gomez-Delgado F; Jimenez-Lucena R; García-Rios A; Vals-Delgado C; Romero-Baldonado C; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
Clin Nutr; 2020 Feb; 39(2):492-500. PubMed ID: 30852029
[TBL] [Abstract][Full Text] [Related]
10. Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study.
Gutierrez-Mariscal FM; Alcalá-Diaz JF; Quintana-Navarro GM; de la Cruz-Ares S; Torres-Peña JD; Cardelo MP; Arenas-Larriva AP; Malagón MM; Romero-Cabrera JL; Ordovás JM; Pérez-Martínez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
Eur J Nutr; 2023 Jun; 62(4):1903-1913. PubMed ID: 36869909
[TBL] [Abstract][Full Text] [Related]
11. Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial.
Yubero-Serrano EM; Fernandez-Gandara C; Garcia-Rios A; Rangel-Zuñiga OA; Gutierrez-Mariscal FM; Torres-Peña JD; Marin C; Lopez-Moreno J; Castaño JP; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Lopez-Miranda J
PLoS Med; 2020 Sep; 17(9):e1003282. PubMed ID: 32903262
[TBL] [Abstract][Full Text] [Related]
12. Does dietary fat affect advanced glycation end products and their receptors? A systematic review of clinical trials.
Mendes NP; Ribeiro PVM; Alfenas RCG
Nutr Rev; 2022 Feb; 80(3):598-612. PubMed ID: 34871448
[TBL] [Abstract][Full Text] [Related]
13. Mediterranean Diet, Glucose Homeostasis, and Inflammasome Genetic Variants: The CORDIOPREV Study.
Roncero-Ramos I; Rangel-Zuñiga OA; Lopez-Moreno J; Alcala-Diaz JF; Perez-Martinez P; Jimenez-Lucena R; Castaño JP; Roche HM; Delgado-Lista J; Ordovas JM; Camargo A; Lopez-Miranda J
Mol Nutr Food Res; 2018 May; 62(9):e1700960. PubMed ID: 29573224
[TBL] [Abstract][Full Text] [Related]
14. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
[TBL] [Abstract][Full Text] [Related]
15. Diabetes Remission Is Modulated by Branched Chain Amino Acids According to the Diet Consumed: From the CORDIOPREV Study.
Cardelo MP; Alcala-Diaz JF; Gutierrez-Mariscal FM; Lopez-Moreno J; Villasanta-Gonzalez A; Arenas-de Larriva AP; Cruz-Ares S; Delgado-Lista J; Rodriguez-Cantalejo F; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
Mol Nutr Food Res; 2022 Feb; 66(4):e2100652. PubMed ID: 34863046
[TBL] [Abstract][Full Text] [Related]
16. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.
de Courten B; de Courten MP; Soldatos G; Dougherty SL; Straznicky N; Schlaich M; Sourris KC; Chand V; Scheijen JL; Kingwell BA; Cooper ME; Schalkwijk CG; Walker KZ; Forbes JM
Am J Clin Nutr; 2016 Jun; 103(6):1426-33. PubMed ID: 27030534
[TBL] [Abstract][Full Text] [Related]
17. Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.
Ojeda-Rodriguez A; Rangel-Zuñiga OA; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Torres-Peña JD; Romero-Cabrera JL; Podadera-Herreros A; García-Fernandez H; Porras-Pérez E; Luque RM; Kales SN; Perez-Martinez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
Cardiovasc Diabetol; 2024 Mar; 23(1):98. PubMed ID: 38493287
[TBL] [Abstract][Full Text] [Related]
18. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
[TBL] [Abstract][Full Text] [Related]
20. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.
Uribarri J; Cai W; Ramdas M; Goodman S; Pyzik R; Chen X; Zhu L; Striker GE; Vlassara H
Diabetes Care; 2011 Jul; 34(7):1610-6. PubMed ID: 21709297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
